title: Postoperative posterior spinal wound infections.
abstract: The incidence of postoperative spinal infections increases with the complexity of the procedure. Diskectomy is associated with less than a 1% risk of infection; spinal fusion without instrumentation is associated with a 1%-5% risk; and fusion with instrumentation may be associated with a risk of 6% or more. Twenty-two postoperative posterior spinal infections that occurred during a three-year period were reviewed for this report. Staphylococcus aureus was the most frequent organism cultured (more than 50% of the cases). Other recurring organisms were Staphylococcus epidermis, Peptococcus, Enterobacter cloacae, and Bacteroides. Many patients had multiple organisms. Risk factors appeared to include advanced age, prolonged hospital bed rest, obesity, diabetes, immunosuppression, and infection at remote sites. Operative factors included prolonged surgery (greater than five hours), high volume of personnel moving through the operating room, and instrumentation. Postoperative contamination may occur and may be related to prolonged postoperative bed rest, skin maceration (thoracolumbosacral orthoses), and drainage tubes exiting distally from lumbar wounds (toward the rectum). Effective treatment includes early diagnosis, surgical debridement and irrigation, and parenteral antibiotics. Superficial infections were treated successfully with wound closure over outflow tubes, and deep infections with inflow-outflow systems. Maintaining the instrumentation in place was possible in most cases. Parenteral antibiotics were maintained for six weeks in every case.
authors.affiliation: Department of Orthopaedic Surgery, University of California, San Diego.
authors.forename: J B
authors.initials: JB
authors.lastname: Massie
authors.forename: J G
authors.initials: JG
authors.lastname: Heller
authors.forename: J J
authors.initials: JJ
authors.lastname: Abitbol
authors.forename: D
authors.initials: D
authors.lastname: McPherson
authors.forename: S R
authors.initials: SR
authors.lastname: Garfin
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006801:Humans; D016268:Internal Fixators / Q000009:adverse effects; D011292:Premedication; D012307:Risk Factors; D013123:Spinal Fusion / Q000009:adverse effects; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013530:Surgical Wound Infection / Q000382:microbiology* / Q000517:prevention & control / Q000628:therapy; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents